This Article Full Text Full Text (PDF) All Versions of this Article: 92/9/3436    most recent Author Manuscript (PDF) Submit a related Letter to the Editor View responses Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zimmermann, M. B. Articles by Hurrell, R. F. Search for Related Content PubMed PubMed Citation Articles by Zimmermann, M. B. Articles by Hurrell, R. F. Related Collections Pediatric Endocrinology Thyroid Female Endocrinology

Iron Deficiency Predicts Poor Maternal Thyroid Status during Pregnancy

Laboratory for Human Nutrition (M.B.Z., R.F.H.), Swiss Federal Institute of Technology (Eidgenössische Technische Hochschule), CH-8092 Zürich, Switzerland; and Committee for Fluoride-Iodine Fortification of Salt (M.B.Z., H.B.), Swiss Academy of Medical Science, CH-3007 Bern, Switzerland; Division of Human Nutrition (M.B.Z.), Wageningen University, 6700 Wageningen, The Netherlands

Address all correspondence and requests for reprints to: Michael B. Zimmermann, M.D., Laboratory for Human Nutrition, Swiss Federal Institute of Technology (Eidgenössische Technische Hochschule) Zürich, Schmelzbergstrasse 7, LFV E 19, CH-8092 Zürich, Switzerland. E-mail: michael.zimmermann{at}ilw.agrl.ethz.ch.

Context: Pregnant women are often iron deficient, and iron deficiency has adverse effects on thyroid metabolism. Impaired maternal thyroid function during pregnancy may cause neurodevelopmental delays in the offspring.

Objective: Our objective was to investigate whether maternal iron status is a determinant of TSH and/or total T₄ (TT4) concentrations during pregnancy.

Design and Outcome Measures: In a representative national sample of Swiss pregnant women (n = 365) in the second and third trimester, samples of urine and blood were collected, and data on maternal characteristics and supplement use were recorded. Concentrations of TSH, TT4, hemoglobin, mean corpuscular volume, serum ferritin, transferrin receptor, and urinary iodine were measured. Body iron stores were calculated and stepwise regressions performed to look for associations.

Results: Median urinary iodine was 139 µg/liter (range 30–433). In the third trimester, nearly 40% of women had negative body iron stores, 16% had a TT4 less than 100 nmol/liter, and 6% had a TSH more than 4.0 mU/liter. Compared with the women with positive body iron stores, the relative risk of a TT4 less than 100 nmol/liter in the group with negative body iron stores was 7.8 (95% confidence interval 4.1; 14.9). Of the 12 women with TSH more than 4.0 mU/liter, 10 had negative body iron stores. Serum ferritin, transferrin receptor, and body iron stores were highly significant predictors of TSH (standardized ß: –0.506, 0.602, and –0.589, respectively; all P < 0.0001) and TT4 (standardized ß: 0.679, –0.589, and 0.659, respectively; all P < 0.0001).

Conclusion: Poor maternal iron status predicts both higher TSH and lower TT4 concentrations during pregnancy in an area of borderline iodine deficiency.

eLetters: